Darbepoetin alfa.
Vance
Renita
R
Swedish Medical Center, Seattle, WA, USA. Renita.Vance@swedish.org
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D000068256:Darbepoetin alfa; D016903:Drug Monitoring / Q000451:nursing; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D006454:Hemoglobins / Q000187:drug effects; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D008657:Metabolic Clearance Rate; D009369:Neoplasms / Q000150:complications / Q000628:therapy; D024802:Nurse's Role; D009730:Nursing Assessment; D010353:Patient Education as Topic; D018579:Patient Selection
D006454:Hemoglobins; D004921:Erythropoietin; D000068256:Darbepoetin alfa